NOXXON Pharma's IPO

NOXXON Pharma raised a round of funding on September 30, 2016. Investors include Public.

Noxxon Pharma specializes in research and development of therapeutic products intended for the treatment of cancers.At the end of 2015, the company has a portfolio of 2 products in clinical developmen…

Articles about NOXXON Pharma's IPO: